"Having validated its novel platform for discovery of functionally active delivery reagents the company is actively pursuing expressions of interest from multiple potential partners."
Looks like the deal pipeline is filling up!
The EET is:
- targeted to an individual cell type
- efficient, in terms of releasing active payload into the cell
- comes with complete screening technology to support an idea-to-drug discovery process
This is only one application of the much broader Phylomer technology! Happy time ahead!!
drugs 25 to 50 x more effective, page-10
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $466.6M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.8¢ | $519.2K | 5.169M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 182466 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 101115 | 2 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |